Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nice. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

Nice (NICE) has been on a downward spiral lately with significant selling pressure. After declining 27.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is over ...

Nice (NICE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this software company have returned -19.7% over the past month versus the Zacks S&P 500 composite's +3.2% change. The Zacks Internet - Software industry, to which Nice belongs, has lost 0.4% over this period. Now the key question is: Where could the stock be headed in the near term? While media releases or ru ...

Nice (NICE) is expanding its footprint in the global public sector with the recent deployment of the NICE Inform solution within Italy’s national police force, the Carabinieri.Headquartered in Rome and comprising 110,000 sworn officers, the Carabinieri will utilize the NICE Inform solution across 514 emergency communication centers, which handle more than seven million emergency calls annually.By implementing NICE Inform, a pivotal component of the NICE Evidencentral platform, which is already used by more ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Nice (NICE) .Nice currently has an average brokerage recommendation (ABR) ...

Nice (NICE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this software company have returned -16.3% over the past month versus the Zacks S&P 500 composite's +4% change. The Zacks Internet - Software industry, to which Nice belongs, has lost 3% over this period. Now the key question is: Where could the stock be headed in the near term?While media releases or rumors about a ...

BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced the National Institute for Health and Care Excellence (NICE) has issued guidance that recommends IMCIVREE® (setmelanotide) as an option for treating obesity and the control of hunger (hyperphagia) in genetically confirmed Bardet-Biedl syndrome (BBS) i ...

A downtrend has been apparent in Nice (NICE) lately with too much selling pressure. The stock has declined 10.6% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting w ...

Nice (NICE) reported adjusted earnings of $2.58 per share in first-quarter 2024, beating the Zacks Consensus Estimate by 5.31% and increasing 27% year over year.Non-GAAP revenues of $659 million trumped the consensus mark by 0.69% and rose 15% year over year. The uptick was primarily driven by the continued strength of its cloud business and the ongoing expansion of its customer base.Revenues in Americas were $559 million, up 18% year over year. The same in EMEA was $67 million in the reported quarter, up 7 ...

财务数据和关键指标变化 - 公司总收入达到6.59亿美元,达到了指导区间的高端,同比增长15% [13] - 云业务收入增长27%,达到4.68亿美元,占总收入的71% [34] - 服务收入为1.49亿美元,占总收入的23%,同比下降7% [35] - 产品收入占总收入的6%,同比下降但超出预期 [35] - 经常性收入占总收入的88%,去年同期为85% [36] - 美洲地区收入占总收入的85%,同比增长18% [37] - 欧洲地区收入占总收入的10%,同比增长7% [37] - 亚太地区收入占总收入的5%,同比略有下降 [37] - 客户互动业务收入达到5.51亿美元,同比增长17% [39] - 金融犯罪和合规业务收入达到1.08亿美元,同比增长8% [39] 各条业务线数据和关键指标变化 - 客户互动业务收入占总收入的84%,同比增长17% [39] - 金融犯罪和合规业务收入占总收入的16%,同比增长8% [39] 各个市场数据和关键指标变化 - 美洲地区收入占总收入的85%,同比增长18% [37] - 欧洲地区收入占总收入的10%,同比增长7% [37] - 亚太地区收入占总收入的5%,同比略有下降 [37] 公司战略和发展方向及行业竞争 - 公司的云业务保持强劲增长,成为公司收入增长的主要驱动力 [34] - 公司的云平台CXone在企业客户中的地位不断提升,在各种评估和招标中保持领先地位 [17][18][19] - 公司的数字化转型战略正在推动客户从分散的点解决方案向统一的CXone平台转移 [19][20][21] - 公司的人工智能(AI)能力正在快速发展,并成为客户选择公司的重要因素 [25][26] 管理层对经营环境和未来前景的评论 - 公司在2024年第一季度保持强劲的财务表现,开局良好 [12] - 公司的云业务、数字化转型和人工智能能力是推动公司持续增长和盈利的关键因素 [15][16] - 公司看好未来的长期增长机会,认为云、数字化和人工智能领域仍有很大的发展空间 [29] 问答环节重要的提问和回答 问题1 **Samad Samana 提问** Barak计划何时过渡离任CEO一职,公司将寻找什么样的特质和经验来选择新CEO? [50][51] **Barak Eilam 回答** 公司将进行有序的CEO过渡,Barak将留任至2024年底,并将在2025年继续为公司提供咨询支持。公司正在内外部寻找具有企业软件行业经验和能够延续公司文化的合适人选。 [55][56][57] 问题2 **Tyler Radke 提问** Barak在即将离任之际,对未来3-5年公司的发展机遇有何期望? [67] **Barak Eilam 回答** 公司在云计算、数字化和人工智能领域仍有巨大的发展空间,加上CXone平台的优势,公司有望实现持续的增长和盈利。 [68] 问题3 **Arjun Bhatia 提问** 公司AI业务的订单增长主要来自于现有客户还是新客户? [88] **Barak Eilam 回答** 公司看到现有客户和新客户对AI能力的需求都在快速增长,客户希望通过AI实现自动化和提升客户体验。公司的AI产品能够满足不同客户在AI应用上的需求。 [89][90]